Literature DB >> 1280436

Effects of amino acid substitutions outside an antigenic site on protein binding to monoclonal antibodies of predetermined specificity obtained by peptide immunization: demonstration with region 94-100 (antigenic site 3) of myoglobin.

M S Abaza1, M Z Atassi.   

Abstract

Amino acid substitutions outside protein antigenic sites are very frequently assumed to exert no effect on binding to antiprotein antibodies, especially if these are monoclonal antibodies (mAbs). In fact, a very popular method for localization of residues in protein antigenic sites is based on the interpretation that whenever a replacement causes a change in binding to antibody, then that residue will be located in the antigenic site. To test this assumption, mAbs of predetermined specificity were prepared by immunization with a free (i.e., without coupling to any carrier) synthetic peptide representing region 94-100 of sperm whale myoglobin (Mb). The cross-reactivities and relative affinities of three mAbs with eight Mb variants were studied. Five Mb variants which had no substitutions within the boundaries of the designed antigenic site exhibited remarkable, and in two cases almost complete, loss in cross-reactivity relative to the reference antigen, sperm whale Mb. Two myoglobins, each of which had one substitution within region 94-100, showed little or no reactivity with the three mAbs. It is concluded that substitutions outside an antigenic site can exert drastic effects on the reactivity of a protein with mAbs against the site and that caution should be exercised in interpreting cross-reactivity data of proteins to implicate residues directly in an antigenic site.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1280436     DOI: 10.1007/BF01025020

Source DB:  PubMed          Journal:  J Protein Chem        ISSN: 0277-8033


  40 in total

1.  The primary sequence of badger myoglobin.

Authors:  D Tetaert; K K Han; M T Plancot; M Dautrevaux; S Ducastaing; I Hombrados; E Neuzil
Journal:  Biochim Biophys Acta       Date:  1974-06-07

2.  California sea lion myoglobin. Complete covalent structure of the polypeptide chain.

Authors:  R A Vigna; L J Gurd; F R Gurd
Journal:  J Biol Chem       Date:  1974-07-10       Impact factor: 5.157

3.  Immunochemistry of some artificial human hemoglobins.

Authors:  M Z Atassi; D J Skalski
Journal:  Immunochemistry       Date:  1969-01

4.  Conformational studies on modified proteins and peptides. Artificial myoglobins prepared with modified and metalloporphyrins.

Authors:  S F Andres; M Z Atassi
Journal:  Biochemistry       Date:  1970-05-26       Impact factor: 3.162

5.  Distance calculation of residues neighbouring to lysozyme antigenic sites. Site-neighbouring residues whose evolutionary substitution can modify the characteristics and binding energy of the sites.

Authors:  M Z Atassi; A L Kazim
Journal:  Biochem J       Date:  1980-04-01       Impact factor: 3.857

6.  The antibody response to myoglobin is independent of the immunized species. Analysis in terms of replacements in the antigenic sites and in environmental residues of the cross-reactions of fifteen myoglobins with sperm-whale myoglobin antisera raised in different species.

Authors:  S S Twining; H Lehmann; M Z Atassi
Journal:  Biochem J       Date:  1980-12-01       Impact factor: 3.857

7.  Nearest-neighbour analysis of myoglobin antigenic sites. Nearest-neighbour residues whose replacement can alter the environment of binding-site residue(s) and thus change their characteristics and binding capability.

Authors:  A L Kazim; M Z Atassi
Journal:  Biochem J       Date:  1980-12-01       Impact factor: 3.857

8.  The myoglobin of an echidna (Tachyglossus aculeatus aculeatus).

Authors:  O Castillo; L T Jones; H Lehmann
Journal:  Biochim Biophys Acta       Date:  1978-04-26

9.  Immunochemistry of sperm-whale myoglobin--XX. Accurate delineation of the single reactive region in sequence 80-103 by immunochemical studies of synthetic peptides.

Authors:  R C Pai; M Z Atassi
Journal:  Immunochemistry       Date:  1975-04

10.  Antibodies with preselected specificities to protein regions evoked by immunization with free synthetic peptides: dose response to myoglobin antigenic sites reveal an optimum dose for each antigenic site.

Authors:  C R Young; H E Schmitz; M Z Atassi
Journal:  Immunol Commun       Date:  1983
View more
  6 in total

1.  Effects of amino acid substitutions outside an antigenic site on protein binding to monoclonal antibodies of predetermined specificity obtained by peptide immunization: demonstration with region 56-62 (antigenic site 2) of myoglobin.

Authors:  M S Abaza; M Z Atassi
Journal:  J Protein Chem       Date:  1992-10

2.  Effects of amino acid substitutions outside an antigenic site on protein binding to monoclonal antibodies of predetermined specificity obtained by peptide immunization: demonstration with region 113-120 (antigenic site 4) of myoglobin.

Authors:  M S Abaza; M Z Atassi
Journal:  J Protein Chem       Date:  1992-12

3.  Effects of amino acid substitutions outside an antigenic site on protein binding to monoclonal antibodies of predetermined specificity obtained by peptide immunization: demonstration with region 15-22 (antigenic site 1) of myoglobin.

Authors:  M S Abaza; C R Young; M Z Atassi
Journal:  J Protein Chem       Date:  1992-10

4.  Effects of amino acid substitutions outside an antigenic site on protein binding to monoclonal antibodies of predetermined specificity obtained by peptide immunization: demonstration with region 145-151 (antigenic site 5) of myoglobin.

Authors:  M S Abaza; M Z Atassi
Journal:  J Protein Chem       Date:  1992-12

5.  Noninvasive in vivo imaging of CD4 cells in simian-human immunodeficiency virus (SHIV)-infected nonhuman primates.

Authors:  Michele Di Mascio; Chang H Paik; Jorge A Carrasquillo; Jin-Soo Maeng; Beom-Su Jang; In Soo Shin; Sharat Srinivasula; Russ Byrum; Achilles Neria; William Kopp; Marta Catalfamo; Yoshiaki Nishimura; Keith Reimann; Malcolm Martin; H Clifford Lane
Journal:  Blood       Date:  2009-05-05       Impact factor: 22.113

6.  In vitro inhibition of human malignant brain tumour cell line proliferation by anti-urokinase-type plasminogen activator monoclonal antibodies.

Authors:  M S Abaza; F A Shaban; R K Narayan; M Z Atassi
Journal:  Br J Cancer       Date:  1998-12       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.